MediWound (MDWD) Change in Inventory (2013 - 2026)
MediWound (MDWD) posted Change in Inventory of $655000.0 for Q2 2026, up 195.48% on a QoQ basis from -$686000.0 in Q1 2026, and up 349.05% year-over-year from $145863.7 in Q2 2025.
Powered by 
Analysis
MediWound (MDWD) Change in Inventory (2013 - 2026) Analysis & Trends
MediWound has reported Change in Inventory for 14 years, with the latest figure at $655000.0 in Q2 2026.
- On a quarterly basis, Change in Inventory rose 349.05% year-over-year to $655000.0 in Q2 2026; TTM through Jun 2026 was -$243000.0, a 60.74% increase from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 828.88% from the prior year.
- Change in Inventory was $655000.0 for Q2 2026 at MediWound, up from -$686000.0 in the prior quarter.
- The five-year high for Change in Inventory was $782000.0 in Q4 2023, with the low at -$888000.0 in Q1 2025.
- Average Change in Inventory over 5 years is -$157444.4, with a median of -$188000.0 recorded in 2022.
- The largest YoY upside for Change in Inventory was 792.04% in 2023 against a maximum downside of 1464.86% in 2023.
- Over 5 years, Change in Inventory stood at -$113000.0 in 2022, then jumped by 792.04% to $782000.0 in 2023, then sank by 55.5% to $348000.0 in 2024, then rose by 0.57% to $350000.0 in 2025, then soared by 87.14% to $655000.0 in 2026.
- The last three Change in Inventory figures came in at $655000.0 (Q2 2026), -$686000.0 (Q1 2026), and $350000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 655,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 655,000.00 |
| Mar 31, 2026 | -686,000.00 |
| Dec 31, 2025 | 350,000.00 |
| Sep 30, 2025 | -562,000.00 |
| Jun 30, 2025 | -263,000.00 |
| Mar 31, 2025 | -888,000.00 |
| Dec 31, 2024 | 348,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 103,000.00 |
| Mar 31, 2024 | -448,000.00 |
| Dec 31, 2023 | 782,000.00 |
| Sep 30, 2023 | -526,000.00 |
| Jun 30, 2023 | -579,000.00 |
| Mar 31, 2023 | -583,000.00 |
| Dec 31, 2022 | -113,000.00 |
| Sep 30, 2022 | 139,000.00 |
| Jun 30, 2022 | -37,000.00 |
| Mar 31, 2022 | -710,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 171,000.00 |